:::

學術成果

:::
搜尋
年至

月至


  • 關鍵字搜尋
  • 期刊論文
    學年度著作著作人
    97Chou YH, Chao PL, Tsai MJ, Cheng HH, Chen KB, Yang DM, Yang CH* and Lin MY.,2008,Arsenite-induced cytotoxicity in dorsal root ganglion explants.,Free Radical Biol. Med.,44,5,pp1553-1561 (SCI)楊志新
    97Chen JP, Lo Y, Yu CJ, Hsu C, Shih JY and Yang CH*,2008,Predictors of toxicity of weekly Docetaxel in chemotherapy-treated nonsmall cell lung cancers.,Lung cancer,60,1,pp92-97 (SCI)楊志新
    97Gow CH, Chien CR, Chang YL, Chiu YH, Shih JY, Chang YC, Yu CJ, Yang CH and Yang PC.,2008,Radiotherapy in Lung Adenocarcinoma with Brain Metastases: Effects of Activating Epidermal Growth Factor Receptor Mutations on Clinical Response.,Clinical Cancer Research,14,1,pp162-168 (SCI)楊志新
    97Ho CC, Kuo SH, Huang PH, Huang HY, Yang CH and Yang PC.,2008,Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy. ,Lung Cancer. ,59,1,pp105-110 (SCI)楊志新
    97Yang CH*, Yu CJ, Shih JY, Chang YC, Hu FC, Tsai MC, Chen KY, Lin ZZ, Huang CJ, Shun CT, Huang CL, Bean J, Pao W and Yang PC. ,2008,Specific EGFR mutations predict treatment outcome of stage III/IV chemonaive NSCLC patients receiving first-line gefitinib monotherapy.,Journal of Clinical Oncology,26,pp2745-2753 (SCI)楊志新
    97Yang CH*. ,2008,EGFR tyrosine kinase inhibitors for the treatment of non-small cell lung cancer in East Asia: present and future (review),Lung Cancer ,60,ppS23-S30 (SCI)楊志新
    97Wu SG, Chang YL, Hsu YC, Wu JY, Yang CH, Yu CJ, Tsai MF, Shih JY, Yang PC.,2008,Good Response to Gefitinib in Lung Adenocarcinoma of Complex Epidermal Growth Factor Receptor (EGFR) Mutations with the Classical Mutation Pattern.,Oncologist.,13,12,pp1276-1284 (SCI)楊志新
    97Hsu C, Kuo SH, Hu FC, Cheng AL, Shih JY, Yu CJ, Lin CC, Huang TC, Yang PC, Yang CH*.,2008,Gemcitabine plus Conventional-dose Epirubicin versus Gemcitabine plus Cisplatin as First-line Chemotherapy for Stage IIIB/IV Non-Small Cell Lung Carcinoma-A randomized phase II trial., Lung Cancer,62,pp334-343 (SCI)楊志新
    97Lin CC, Pu YS, Hsu CH, Keng HY, Cheng AL and Yang CH*.,2008,Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma.,Urologic Oncology: Seminars and Original Investigations ,26,6,pp659-661 (SCI)楊志新
    96Bean J, Brennan C, Shih JY, Riely G, Viale A, Wang L, Chitale D, Moti N, Szoke J, Broderick S, Balak M, Chang WC, Yu CJ, Gazdar A, Pass H, Rusch V, Geral W, Huang SF, Yang PC, Miller V, Ladayi M, Yang CH and W Pao.,2007,MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.,Proc Natl Acad Sci ,104,52,pp20932-20937 (SCI)楊志新